Scope of the Issue
Pediatric asthma remains one of the most significant chronic health conditions affecting children in the United States. According to the CDC, approximately 6.5% of U.S. children under age 18 currently have asthma, representing about 4.7 million children nationwide. Asthma is a leading cause of emergency department visits, hospitalizations, and missed school days, disproportionately affecting low‑income families and communities of color.
Health Impact on Children
Asthma in childhood is characterized by chronic airway inflammation, recurrent wheezing, coughing, chest tightness, and difficulty breathing. These symptoms often worsen with viral infections, allergens, exercise, and environmental exposures such as air pollution or tobacco smoke.
Key impacts include:
- 1 in 15 children lives with asthma.
- Asthma is a top cause of school absenteeism, contributing to millions of missed school days annually.
- Children experience higher rates of emergency department visits compared to adults due to smaller airways and heightened sensitivity to triggers.
Healthcare Utilization & Economic Burden
Asthma drives substantial healthcare use and economic costs:
- 1.4 million emergency department visits occur annually for asthma (all ages), with children representing a significant share.
- Nationally, asthma contributes to:
- Increased hospitalizations
- Frequent outpatient visits
- High use of rescue medications
- The total economic burden of asthma in the U.S. (all ages) exceeds $80 billion annually, including:
- Direct medical costs
- Indirect costs such as lost caregiver workdays
- Reduced productivity and long‑term health impacts
Children with uncontrolled asthma often require repeated urgent care, creating financial strain on families and healthcare systems.
Disparities
Asthma prevalence and outcomes are not evenly distributed:
- Black and Puerto Rican children experience higher asthma rates and more severe outcomes.
- Children in low‑income households face greater exposure to environmental triggers such as mold, pests, and poor air quality.
- Access to consistent primary care and controller medications varies widely by geography and insurance status.
Evidence‑Based Strategies for Improvement
National guidelines emphasize:
- Daily controller medications (inhaled corticosteroids) for persistent asthma
- Asthma Action Plans shared with families, schools, and caregivers
- Environmental trigger reduction, including indoor air quality improvements
- Regular follow‑up visits to adjust treatment as children grow
- School‑based asthma programs, which have been shown to reduce absenteeism and emergency visits